%0 Journal Article
%K Adalimumab
%K Antibodies, Monoclonal
%K Antibodies, Monoclonal, Humanized
%K Arthritis, Rheumatoid
%K Humans
%K Leprosy, Borderline
%K Male
%K Middle Aged
%B Archives of dermatology
%D 2009
%G eng
%N 3
%P 349-51
%R 10.1001/archdermatol.2009.10
%T Type 1 leprosy reaction manifesting after discontinuation of adalimumab therapy.
%V 145
%1 http://www.ncbi.nlm.nih.gov/pubmed/19289788?dopt=Abstract
%8 2009 Mar